Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Eledon Pharamceuticals (ELDN)

November 20, 2024 7:26 AM EST Send to a Friend
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating and $16.00 price target on Eledon Pharamceuticals (NASDAQ: ELDN).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login